Alexion Pharmaceuticals, Inc announced topline results from the REGAIN study, a Phase 3 registration trial of eculizumab (Soliris®) in patients...
Read moreNatco Pharma Limited announced that its marketing partner, Mylan Inc has received a tentative approval for its Abbreviated New Drug...
Read more
Visionary, up to $2 billion multi-year alliance to focus on development of new gene therapy and gene editing technologies and...
Read more
CPhI& P-MEC China will be held in Shanghai New International Expo Center on June 21-23, 2016.Bearing 15-year trust of the...
Read moreThree Pharmaceutical Companies with Research Bases in Japan Work Together to Accelerate Innovation in Japan-Originated Drug DiscoveryAstellas Pharma Inc ,...
Read moreBardoxolone Methyl (RTA 402) Data Show Improvement in Renal Function by Inulin Clearance in a Phase II Clinical Study in...
Read moreMerck, a leading science and technology company, today announced that it signed a letter of intent on innovation and digitalization...
Read moreChugai Pharmaceutical Co Ltd announced that the results of the Japanese phase III study (J-ALEX) of Alecensa®, in ALK fusion...
Read moreSubjects received one-time administration of a highly optimized gene therapy at initial low dose without the need for immunosuppression Therapeutic...
Read moreData presentations further evaluate HUMIRA® (adalimumab) for the treatment of inflammatory bowel diseases including moderate to severe Crohn's disease in...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
